AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
The study was designed to find the optimum AVN944 dose to use in combination with gemcitabine in patients with pancreatic cancer and see if the combination of the 2 drugs was more effective for treating pancreatic cancer than using gemcitabine alone.
Pancreatic Cancer
DRUG: AVN944
Safety, 4 weeks|Pharmacokinetics, Days 1, 8, 15, and 22
The study was designed to find the optimum AVN944 dose to use in combination with gemcitabine in patients with pancreatic cancer and see if the combination of the 2 drugs was more effective for treating pancreatic cancer than using gemcitabine alone.